DK1242067T3 - Calciumformiat som et kosttilskud - Google Patents

Calciumformiat som et kosttilskud

Info

Publication number
DK1242067T3
DK1242067T3 DK00988258T DK00988258T DK1242067T3 DK 1242067 T3 DK1242067 T3 DK 1242067T3 DK 00988258 T DK00988258 T DK 00988258T DK 00988258 T DK00988258 T DK 00988258T DK 1242067 T3 DK1242067 T3 DK 1242067T3
Authority
DK
Denmark
Prior art keywords
calcium formate
dietary supplement
calcium
formate
individual
Prior art date
Application number
DK00988258T
Other languages
Danish (da)
English (en)
Inventor
Hector F Deluca
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27042788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1242067(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/469,513 external-priority patent/US6160016A/en
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of DK1242067T3 publication Critical patent/DK1242067T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00988258T 1999-12-22 2000-12-21 Calciumformiat som et kosttilskud DK1242067T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/469,513 US6160016A (en) 1999-12-22 1999-12-22 Phosphorus binder
US09/649,710 US6489361B1 (en) 1999-12-22 2000-08-25 Phosphorus binder

Publications (1)

Publication Number Publication Date
DK1242067T3 true DK1242067T3 (da) 2006-11-27

Family

ID=27042788

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00988258T DK1242067T3 (da) 1999-12-22 2000-12-21 Calciumformiat som et kosttilskud

Country Status (11)

Country Link
US (10) US20010016603A1 (el)
EP (1) EP1242067B1 (el)
JP (1) JP2003518058A (el)
AT (1) ATE333871T1 (el)
AU (1) AU782649B2 (el)
CA (1) CA2395530C (el)
CY (1) CY1105732T1 (el)
DE (1) DE60029628T2 (el)
DK (1) DK1242067T3 (el)
ES (1) ES2269218T3 (el)
WO (1) WO2001045695A2 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU782649B2 (en) * 1999-12-22 2005-08-18 Wisconsin Alumni Research Foundation Calcium formate for use as a phosphorus binder and a dietary supplement
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20060029641A1 (en) * 2004-08-05 2006-02-09 Keller Nathan I Calcium and magnesium nutritional supplement
CA2583548A1 (en) * 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden
US20080058250A1 (en) * 2005-08-17 2008-03-06 Allison Wren Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods
EP2252274A4 (en) * 2008-02-20 2011-05-11 Univ Missouri COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME
CN103037870B (zh) 2010-05-12 2016-05-25 斯派克托姆制药公司 碱式碳酸镧、碳酸氧镧及其制造方法和用途
US20160053281A1 (en) 2013-08-15 2016-02-25 The University Court Of The University Of Edinburgh Enhanced Expression Of RNA Vectors

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191835A (en) * 1936-09-24 1940-02-27 Allentown Marjorie G Snelling Food process and product
US2266992A (en) 1939-03-15 1941-12-23 American Cyanamid Co Therapeutic composition
US2471144A (en) * 1948-12-02 1949-05-24 Sterling Drug Inc Salt substitute
US2596333A (en) * 1951-04-03 1952-05-13 Fougera & Co Inc E Dietary salt substitute
US3558786A (en) 1963-08-15 1971-01-26 Geigy Chem Corp Feed composition and its utilization
US3709696A (en) * 1971-05-06 1973-01-09 Barrera R Tortilla and process using hydrophilic inorganic gels
FR2196151A1 (en) 1972-08-18 1974-03-15 Grimberg George Dietetic sodium-free salt mixture - for use by patients with renal insuffic--iency or hypertension
CA1066617A (en) 1975-11-27 1979-11-20 John J. Huitson Liquid composition containing formic acid
JPS589663B2 (ja) * 1976-06-30 1983-02-22 キッコーマン株式会社 醸造食品の製造法
JPS59154053A (ja) 1983-02-22 1984-09-03 Takeshi Amakawa 半導体成形品におけるリ−ド折曲方法及び装置
US4851221A (en) * 1985-02-19 1989-07-25 Mission Pharmacal Company Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid
DE3628249C1 (de) * 1986-08-20 1987-11-26 Degussa Mittel zur Verbesserung des Wachstums und der Futterverwertung bei Schweinen
US4870105B1 (en) * 1987-04-07 1998-03-10 Braintree Lab Phosphorus binder
DK159807C (da) * 1989-02-27 1992-06-29 Gunnar Kjems Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber
US4970079A (en) * 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
GB2254536B (en) * 1991-04-08 1994-10-05 Petrella Ltd A food product
PH31657A (en) * 1992-02-13 1999-01-12 Shiao Shin Jen Areca food additives and its foods.
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5589197A (en) 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution
US6159503A (en) * 1993-12-02 2000-12-12 Hercules Incorporated Pectin process and composition
DE4402544C2 (de) * 1994-01-28 1996-01-18 Chevita Gmbh Veterinärmedizinische Verwendung von Calciumformiat in Gel- oder Pastenform
CA2122863C (en) * 1994-05-04 1997-05-20 Jacques Jalbert Animal food supplement briquette
US5637312A (en) * 1995-03-29 1997-06-10 Tock; Richard W. Digestion enhancer for ruminant animals comprising a formate salt
US5698222A (en) 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
DE19528524C2 (de) * 1995-08-03 1999-11-11 Hans Dietl Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung
US5645853A (en) * 1995-08-08 1997-07-08 Enamelon Inc. Chewing gum compositions and the use thereof for remineralization of lesions in teeth
US5571502A (en) * 1995-08-08 1996-11-05 Enamelon Research Stable single-part compositions and the use thereof for remineralization of lesions in teeth
GB9603518D0 (en) * 1996-02-20 1996-04-17 Smithkline Beecham Plc Novel process
US5945144A (en) * 1996-07-08 1999-08-31 Hahn; David H. Calcium fortified pasta and process of making
ATE207732T1 (de) * 1996-09-12 2001-11-15 Smithkline Beecham Consumer Zusammensetzung zur remineralisierung
US5817296A (en) * 1996-09-27 1998-10-06 Enamelon, Inc. Processes and compositions for the remineralization of teeth
US5958380A (en) * 1997-07-07 1999-09-28 Enamelon, Inc. Chewing gum products and the use thereof for remineralizing subsurface dental lesions and for mineralizing exposed dentinal tubules
DE19753321A1 (de) * 1997-12-02 1999-06-10 Basf Ag Verfahren zur Herstellung und Verwendung von Lysinformiat
US5905093A (en) 1998-02-17 1999-05-18 Nadia Achkar Fish scale extract as a calcium supplement
US6303104B1 (en) * 1999-02-12 2001-10-16 Enamelon, Inc. Remineralizing/mineralizing oral products having improved whitening and stain removal properties
AU782649B2 (en) * 1999-12-22 2005-08-18 Wisconsin Alumni Research Foundation Calcium formate for use as a phosphorus binder and a dietary supplement
US6160016A (en) * 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder

Also Published As

Publication number Publication date
WO2001045695A3 (en) 2002-01-03
DE60029628D1 (de) 2006-09-07
EP1242067B1 (en) 2006-07-26
US20170049808A1 (en) 2017-02-23
US20110059927A1 (en) 2011-03-10
US20010016603A1 (en) 2001-08-23
US20120046252A1 (en) 2012-02-23
WO2001045695A2 (en) 2001-06-28
US20030100609A1 (en) 2003-05-29
CA2395530A1 (en) 2001-06-28
US20020035151A1 (en) 2002-03-21
DE60029628T2 (de) 2007-07-26
US6528542B2 (en) 2003-03-04
US20170246206A1 (en) 2017-08-31
CY1105732T1 (el) 2010-12-22
EP1242067A2 (en) 2002-09-25
US20040029964A1 (en) 2004-02-12
CA2395530C (en) 2008-07-15
AU782649B2 (en) 2005-08-18
US20050106234A1 (en) 2005-05-19
US20140155360A1 (en) 2014-06-05
AU2448501A (en) 2001-07-03
ATE333871T1 (de) 2006-08-15
ES2269218T3 (es) 2007-04-01
JP2003518058A (ja) 2003-06-03
US7850991B2 (en) 2010-12-14

Similar Documents

Publication Publication Date Title
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
HK1076605A1 (en) Formulations
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
CY1105732T1 (el) Μυρμηκικο ασβεστιο ως διαιτητικο συμπληρωμα
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
TNSN06013A1 (en) Semi-solid systems containing azetidine derivatives
AR003434A1 (es) Compuesto de tiludronato, composiciones farmaceuticas que los contienen y proceso para producir dicho compuesto y procedimiento para producir lascomposiciones farmaceuticas.
IS6919A (is) Stöðug lyfjablanda sem felur í sér torsemíð afbrigði II
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
TR200100887T2 (tr) LH-RH analoglarının ağız yoluyla verilmesi için alfa-siklodekstrin esaslı farmasötik terkipler
DK1365810T3 (da) Calciumsupplement til formindskelse af risikoen for prostatacancer
MX9909548A (es) Metodos para la reduccion de fibrinogenos.
HN1996003617A (es) Formulaciones farmaceuticas
ATE429905T1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung